Skip to search.
 BSE Down 0.38% NSE Down 0.37%
Streaming
Ticker Tape: On

Dyax Corp. (DYAX)

-NasdaqGM

3.23 Up 0.10(3.19%) 19 Jun 1:30AM|After Hours : 3.23 0.00 (0.00%) 19 Jun 2:01AM

Add to Portfolio
Prev Close:3.13
Open:3.15
Bid:N/A
Ask:4.99 x 200
1y Target Est:4.67
Beta:0.81
Next Earnings Date:15-Jul-13DYAX Earnings announcement
Day's Range:3.08 - 3.24
52wk Range:2.02 - 4.50
Volume:688,546
Avg Vol (3m):730,098
Market Cap:323.82M
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for DYAX at this time.

Comparison

Symbol% ChgMkt Cap
DYAXUp 3.19%323.82M
RHHBYN.MXUp 1.64%2.74T
SHP.LDown 0.33%11.52B
SUNPHARMA.NSUp 0.14%1.00T
GILD.MXUp 2.37%1.02T
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.68
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-0.27
Quarterly EPS Est (Jun-13) :-0.06
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-2.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, engages in the identification, development, and commercialization of treatments for plasma kallikrein-mediated (PKM) angioedemas. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback